MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-19-0097008
Pharma Access Private Limited - engineering in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹230.97 Cr
▲ 31% YoY
Net profit · FY 2025
₹24.66 Cr
Net margin 10.7%
EBITDA · FY 2025
₹38.19 Cr
EBITDA margin 16.5%
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹202.47 Cr
Secured borrowings
Company age
13 yrs
Est. 2013
Employees · EPFO
135
Provident fund records
About Pharma Access Private Limited
Data last updated:
Pharma Access Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the engineering sector. It was incorporated on 13 August 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2013PTC246924. Its GSTIN is 27AAHCP5467G1Z3 (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹1 Lakh. It is led by directors Nilofer Shams Ahmad Parvaz (Whole-Time Director) and Shams Ahmad Asghar Ali Parvaz (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 702 Supreme Chambers Shah Industrial Estate Near Veera Desai Andheri West, Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2025, the company reported a revenue of ₹230.97 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹24.66 Cr (net margin 10.7%) and EBITDA of ₹38.19 Cr (EBITDA margin 16.5%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 13% over five years.
The company has about 135 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pharmaaccess. As per MCA filings, the company has open charges of ₹202.47 Cr on record. Court records list 8 cases involving the company, including 7 filed by the company and 1 filed against it; 1 case is pending.
Pharma Access Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0097008). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmaaccess.net.
Company Details of Pharma Access Private Limited
CIN U74120MH2013PTC246924
Registration Number 246924
Incorporation Date 13 August 2013
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-19-0097008
Key People
Nilofer Shams Ahmad Parvaz Whole-Time Director Shams Ahmad Asghar Ali Parvaz Whole-Time Director Recognitions & Rankings of Pharma Access
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address702 Supreme Chambers Shah Industrial Estate Near Veera Desai Andheri West, Mumbai, Maharashtra, India – 400053
- IndustryEngineering, Engineering, Procurement & Construction (EPC)
Comprehensive company report
Pharma Access Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Pharma Access Private Limited
Pharma Access operates one associated brand: Pharmaaccess. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Delivers engineering, design, construction, and project management for pharma infrastructure globally. | pharmaaccess.net |
Business Activity of Pharma Access Private Limited
The main business activity of Pharma Access is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pharma Access Private Limited FY 2025 filings available
Pharma Access Private Limited reported revenue of ₹230.97 Cr (up 31% YoY) for FY 2025.
Revenue · FY 2025
₹230.97 Cr ▲ 31%
Net profit · FY 2025
₹24.66 Cr margin 10.7%
EBITDA · FY 2025
₹38.19 Cr margin 16.5%
Compounded Annual Growth Rate (CAGR) of Pharma Access Private Limited
Revenue CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 36%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 14%
3 years · compounded
▲ 31%
5 years · compounded
▲ 9%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 31% growth in the latest year. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Pharma Access Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹38.19 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹24.66 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Pharma Access Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 10.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pharma Access are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Pharma Access Private Limited
Pharma Access has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nilofer Shams Ahmad Parvaz | Whole-Time Director | 13 Aug 2013 | 13 Years 2 Months | Current |
| Shams Ahmad Asghar Ali Parvaz | Whole-Time Director | 13 Aug 2013 | 13 Years 2 Months | Current |
Peer Comparison of Pharma Access Private Limited
Pharma Access Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Engineering Design, Engineering Procurement and Construction, Healthcare Equipment Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biotronik Medical Devices India Private Limited. | ₹240.4 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | New Delhi, Delhi, India |
| Pioneer Foundation Engineers Private Limited | ₹240.17 Cr (FY 2025) | •••• | •••• | 57.0% | •••• | Mumbai, Maharashtra, India |
| Revvity Healthcare (India) Private Limited | ₹238.14 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Thane, Maharashtra, India |
| Medihauxe International Private Limited | ₹235.12 Cr (FY 2023) | •••• | •••• | 9.0% | •••• | Hyderabad, Telangana, India |
| Consulting Engineers Group Limited . | ₹231.57 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Jaipur, Rajasthan, India |
| Pharma Access Private Limited this company | ₹230.97 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Mumbai, Maharashtra, India |
| Beico Industries Private Limited | ₹230.32 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| I R Technology Services Private Limited | ₹228.96 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Navi Mumbai, Maharashtra, India |
| Subeno India Private Limited | ₹228.56 Cr (FY 2025) | •••• | •••• | 84.0% | •••• | Pune, Maharashtra, India |
| Mectech Process Engineers Private Limited | ₹228.15 Cr (FY 2025) | •••• | •••• | 64.0% | •••• | New Delhi, Delhi, India |
| Swastik Electrotech Private Limited. | ₹228.07 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Pharma Access by revenue in the Healthcare industry (Engineering Design, Engineering Procurement and Construction, Healthcare Equipment Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Pharma Access Private Limited
Pharma Access Private Limited is audited by musamji & patel for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| musamji & patel | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Pharma Access Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pharma Access Private Limited
Open charges
₹202.47 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 May 2022 | Others | ₹70.74 Cr | Open |
| 08 Nov 2021 | Others | ₹70.74 Cr | Open |
| 28 Jun 2019 | Others | ₹61 Cr | Open |
Total charge records: 3 View all charges
Legal Cases of Pharma Access Private Limited
Pharma Access Private Limited has 8 court cases on record: 7 filed by Pharma Access, 1 filed against it. 1 case is pending and 7 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Total cases
8
Filed by the company
7
Filed against the company
1
Pending
1
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 0 | 1 |
| District courts | 3 | 1 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Arbitration matter | Filed by the company against Clean Coats Private Limited | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed by the company against Clean Coats Private Limited | Disposed |
| Bombay High Court | Court case (S) | Filed by the company against Clean Coats Private Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Union of India | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
Premium access
Full case history
All 8 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Pharma Access Private Limited
Pharma Access Private Limited has a workforce of 135 employees as of Mar 26, 2024.
Employee count
135
Active EPFO establishments
1
Employee growth
9.76%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pharma Access Private Limited
Pharma Access Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Nilofer Shams Ahmad Parvaz ceased to be Director on 16 Jan 2025.
AGM
Pharma Access Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Pharma Access Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Nilofer Shams Ahmad Parvaz ceased to be Director.
Ceased
Shams Ahmad Asghar Ali Parvaz ceased to be Director.
Charges
A charge with Others of Rs. 61.00 Cr registered on 28 Jun 2019 with Charge ID 100276089 was modified on 01 Aug 2024.
Charges
A charge with Others of Rs. 70.74 Cr registered on 12 May 2022 with Charge ID 100573829 was modified on 28 Feb 2023.
Charges
A charge with Others amounted to Rs. 70.74 Cr with Charge ID 100573829 was registered on 12 May 2022.
Charges
A charge with Others amounted to Rs. 70.74 Cr with Charge ID 100496389 was registered on 08 Nov 2021.
Charges
A charge with Others amounted to Rs. 61.00 Cr with Charge ID 100276089 was registered on 28 Jun 2019.
Appointed
Nilofer Shams Ahmad Parvaz was appointed as Whole-Time Director.
Appointed
Shams Ahmad Asghar Ali Parvaz was appointed as Whole-Time Director.
Incorporation
13 Aug 2013
Pharma Access Private Limited was registered on 13 Aug 2013 with Roc Mumbai & aged 13 years 2 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Pharma Access Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pharma Access Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pharma Access Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pharma Access Private Limited
Pharma Access has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCP5467G1Z3 | Maharashtra | Active | 01 Jul 2017 |
| 37AAHCP5467G1Z2 | Andhra Pradesh | Active | 31 Mar 2022 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pharma Access Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharma Access Private Limited
Pharma Access is an active private limited company based in Mumbai, Maharashtra, India. The company works in the engineering industry. It was incorporated on 13 August 2013 (13+ years old) and is registered under CIN U74120MH2013PTC246924.
Pharma Access reported revenue of ₹230.97 Cr for FY 2025 (up 31% YoY).
Pharma Access has 2 current directors:
- Nilofer Shams Ahmad Parvaz - Whole-Time Director
- Shams Ahmad Asghar Ali Parvaz - Whole-Time Director
Pharma Access reported a net profit of ₹24.66 Cr (net margin 10.7%) and EBITDA of ₹38.19 Cr (EBITDA margin 16.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Pharma Access is 36% over three years and 13% over five years. In the latest year (FY 2025) revenue rose 31%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Pharma Access is 27AAHCP5467G1Z3, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAHCP5467G1Z2 (Andhra Pradesh).
The CIN (Corporate Identification Number) of Pharma Access is U74120MH2013PTC246924. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharma Access has 8 court cases on record: 7 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Pharma Access was incorporated on 13 August 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Pharma Access by revenue are Biotronik Medical Devices India Private Limited, Pioneer Foundation Engineers Private Limited, Revvity Healthcare (India) Private Limited, Medihauxe International Private Limited, Consulting Engineers Group Limited . and 5 more, all in the Healthcare industry (Engineering Design, Engineering Procurement and Construction, Healthcare Equipment Retail and Distribution).
Nilofer Shams Ahmad Parvaz ceased to be Director on 16 Jan 2025. Shams Ahmad Asghar Ali Parvaz ceased to be Director on 16 Jan 2025. Nilofer Shams Ahmad Parvaz was appointed as Whole-Time Director on 13 Aug 2013. Pharma Access has 4 board changes on record in total.